These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24414069)

  • 1. Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart.
    Vimercati C; Qanud K; Mitacchione G; Sosnowska D; Ungvari Z; Sarnari R; Mania D; Patel N; Hintze TH; Gupte SA; Stanley WC; Recchia FA
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H709-17. PubMed ID: 24414069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.
    Badolia R; Ramadurai DKA; Abel ED; Ferrin P; Taleb I; Shankar TS; Krokidi AT; Navankasattusas S; McKellar SH; Yin M; Kfoury AG; Wever-Pinzon O; Fang JC; Selzman CH; Chaudhuri D; Rutter J; Drakos SG
    Circulation; 2020 Jul; 142(3):259-274. PubMed ID: 32351122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure.
    Ekelund UE; Harrison RW; Shokek O; Thakkar RN; Tunin RS; Senzaki H; Kass DA; Marbán E; Hare JM
    Circ Res; 1999 Sep; 85(5):437-45. PubMed ID: 10473673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.
    Gupte SA; Levine RJ; Gupte RS; Young ME; Lionetti V; Labinskyy V; Floyd BC; Ojaimi C; Bellomo M; Wolin MS; Recchia FA
    J Mol Cell Cardiol; 2006 Aug; 41(2):340-9. PubMed ID: 16828794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVT-4325 inhibits myocardial fatty acid uptake and improves left ventricular systolic function without increasing myocardial oxygen consumption in dogs with chronic heart failure.
    Imai M; Rastogi S; Sharma N; Chandler MP; Sharov VG; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
    Cardiovasc Drugs Ther; 2007 Feb; 21(1):9-15. PubMed ID: 17119875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure.
    Qanud K; Mamdani M; Pepe M; Khairallah RJ; Gravel J; Lei B; Gupte SA; Sharov VG; Sabbah HN; Stanley WC; Recchia FA
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2098-105. PubMed ID: 18820029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the pentose phosphate pathway decreases ischemia-reperfusion-induced creatine kinase release in the heart.
    Zuurbier CJ; Eerbeek O; Goedhart PT; Struys EA; Verhoeven NM; Jakobs C; Ince C
    Cardiovasc Res; 2004 Apr; 62(1):145-53. PubMed ID: 15023561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring flux through the oxidative pentose phosphate pathway using [1-14C]gluconate.
    Garlick AP; Moore C; Kruger NJ
    Planta; 2002 Dec; 216(2):265-72. PubMed ID: 12447540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
    Li X; Lu Q; Qiu Y; do Carmo JM; Wang Z; da Silva AA; Mouton A; Omoto ACM; Hall ME; Li J; Hall JE
    J Am Heart Assoc; 2021 Mar; 10(6):e018298. PubMed ID: 33719499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine.
    El Alaoui-Talibi Z; Guendouz A; Moravec M; Moravec J
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1615-24. PubMed ID: 9139943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.
    Bakkehaug JP; Kildal AB; Engstad ET; Boardman N; Næsheim T; Rønning L; Aasum E; Larsen TS; Myrmel T; How OJ
    Circ Heart Fail; 2015 Jul; 8(4):766-75. PubMed ID: 26025342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.
    Osorio JC; Stanley WC; Linke A; Castellari M; Diep QN; Panchal AR; Hintze TH; Lopaschuk GD; Recchia FA
    Circulation; 2002 Jul; 106(5):606-12. PubMed ID: 12147544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
    Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
    J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
    Butter C; Wellnhofer E; Schlegl M; Winbeck G; Fleck E; Sabbah HN
    J Card Fail; 2007 Mar; 13(2):137-42. PubMed ID: 17395055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.
    Seki M; Powers JC; Maruyama S; Zuriaga MA; Wu CL; Kurishima C; Kim L; Johnson J; Poidomani A; Wang T; Muñoz E; Rajan S; Park JY; Walsh K; Recchia FA
    Circ Heart Fail; 2018 Jan; 11(1):e004486. PubMed ID: 29317401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
    Ho KL; Zhang L; Wagg C; Al Batran R; Gopal K; Levasseur J; Leone T; Dyck JRB; Ussher JR; Muoio DM; Kelly DP; Lopaschuk GD
    Cardiovasc Res; 2019 Sep; 115(11):1606-1616. PubMed ID: 30778524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan restores the positive force-frequency relation in heart failure.
    Masutani S; Cheng HJ; Tachibana H; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H488-96. PubMed ID: 21572004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.